Indian benchmark indices continued their decline for the second consecutive day, with Nifty down 135 points to 24,205 and Sensex falling 553 points to 79,389, marking the worst month since March 2020 amid heavy FII outflows and disappointing Q2 earnings.Cipla's shares surged 10% following a positive FDA classification for its Goa facility, allowing the launch of its chemotherapy drug Abraxane. In contrast, IRB Infrastructure Developers saw a drop in shares due to subdued earnings, despite a slight increase in net profit, while Dabur India reported a 17% year-on-year decline in net profit for Q2FY25.